Other Medical Devices - Zimbabwe | Statista Market Forecast

The projected revenue for the Other Medical Devices market market in Zimbabwe is expected to reach US$19.44m in 2024.
Furthermore, it is anticipated that the revenue will display an annual growth rate (CAGR 2024-2029) of 0.29%, leading to a market volume of US$19.71m by 2029.
It is worth mentioning that in a global context, the United States is projected to generate the highest revenue in this market, amounting to US$58.90bn in 2024.
Zimbabwe's Other Medical Devices market is witnessing a surge in demand due to the country's growing healthcare infrastructure and increasing focus on advanced medical technologies.

Definition:
The market Other Medical Devices covers revenues for areas that are not specifically mentioned in the other submarkets, such as endoscopy, drug delivery, dental medicine, wound management, diabetes care, nephrology, neurology, and ENT.

Drug delivery
Wound management

Medical devices covered in other markets
Pharmaceuticals
Services (i.e., treatment expenses)
Consumer technologies, e.g., fitness trackers
Blood and transplants derived from the human body

The Other Medical Devices market in Zimbabwe is experiencing steady growth due to increasing customer preferences for advanced medical technology, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in Zimbabwe are increasingly demanding advanced medical devices that offer higher accuracy, improved efficiency, and better patient outcomes. They are willing to invest in state-of-the-art equipment that can assist in accurate diagnosis and treatment. This preference for advanced technology is driven by the growing awareness among healthcare professionals and patients about the benefits of using modern medical devices.

Trends in the market: One of the key trends in the Other Medical Devices market in Zimbabwe is the adoption of digital health solutions. Healthcare providers are embracing telemedicine, remote patient monitoring, and electronic medical records to improve access to healthcare services, especially in rural areas. This trend is driven by the need to overcome geographical barriers and reach underserved populations. Additionally, there is a growing demand for wearable medical devices, such as fitness trackers and smartwatches, which can monitor vital signs and provide real-time health data.

Local special circumstances: Zimbabwe has a high burden of diseases such as HIV/AIDS, malaria, and tuberculosis. The government and healthcare organizations are investing in medical devices that can aid in the diagnosis, treatment, and management of these diseases. There is also a focus on improving maternal and child healthcare, which has led to an increased demand for medical devices related to obstetrics and gynecology.

Underlying macroeconomic factors: Zimbabwe is experiencing economic growth, which has resulted in increased healthcare spending. The government has allocated significant funds to the healthcare sector, leading to infrastructure development and the purchase of medical equipment. Additionally, the country has a growing middle class with higher disposable incomes, which has contributed to the demand for better healthcare services and medical devices. In conclusion, the Other Medical Devices market in Zimbabwe is witnessing growth due to customer preferences for advanced technology, the adoption of digital health solutions, local special circumstances related to disease burden and healthcare priorities, and underlying macroeconomic factors such as economic growth and increased healthcare spending.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.